•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Guardant Health Prices $500 Million Convertible Senior Notes Offering
Guardant Health Announces Proposed $500.0 Million Offering of Convertible Senior Notes Due 2032
Guardant Health Introduces New Epigenomic Applications Providing Deeper Insights for Treatment Selection with Guardant360® Liquid
PRECISION Study Published in ESMO Open Highlights Utility of Guardant360® Liquid and Guardant Reveal® to Assess Recurrence Risk After Surgery for Colorectal Cancer Metastases
Guardant Health to Participate in Upcoming Investor Conferences
What Guardant Health (GH) Said on Its Q3 Earnings Call
Guardant Health (GH) Reports Q3 Loss, Tops Revenue Estimates
Guardant Health (GH) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Guardant Health Reports Third Quarter 2026 Financial Results and Increases 2026 Revenue Guidance
Countdown to Guardant Health (GH) Q3 Earnings: Wall Street Forecasts for Key Metrics
Kevin Sayer Joins Guardant Health Board of Directors
Guardant Health Wins 2026 Prix Galien USA Award for Best Medical Technology for Shield Blood Test
Guardant Health (GH) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Guardant Health Applauds New Law Ensuring Access to Colorectal Cancer Screening Innovations with No Cost-Sharing for Pennsylvanians
Allspring Emerging Growth Fund: Q3 2026 Top Contributors And Detractors
This Guardant Health Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Here Are Friday’s Top Wall Street Analyst Research Calls: Deckers Outdoor, Globe Life, Guardant Health, Hess Midstream LP, Kimberly-Clark, Natera, NVR, SpaceX, Thermo Fisher Scientific, and More
Guardant Health, Inc. (NASDAQ:GH) Stock Has Average Price Target of $190.00
Guardant Health Highlights Broad Liquid Biopsy Research Portfolio at ESMO Congress 2026